Bremelanotide has phase 3 evidence for hypoactive sexual desire disorder in premenopausal women. Effects were modest, nausea was common, and the evidence does not support broader recreational claims.
Key points
- Phase 3 RECONNECT trials showed small improvements in desire and distress scores.
- Nausea affected a large proportion of participants.
- Transient blood-pressure increases were reported.
- Products sold online under this name have not been independently verified; label identity and concentration cannot be assumed.
What the literature shows
Kingsberg and colleagues reported the two RECONNECT phase 3 trials, with statistically significant but modest changes versus placebo.
Melanocortin-receptor activity links bremelanotide to melanotan II, including possible skin-darkening effects.
What remains unknown
- Evidence in men and in non-indicated uses is limited.
- Effects of frequent repeated use.
Safety and monitoring implications
- People with uncontrolled hypertension or cardiovascular disease face particular concern.
- Focal hyperpigmentation has been reported.
Cited literature
- 1.Kingsberg SA, Clayton AH, Portman D, et al. (2019). Bremelanotide for the treatment of hypoactive sexual desire disorder: two randomized phase 3 trials. Obstetrics and Gynecology. Find on PubMed
- 2.Clayton AH, Kingsberg SA, Portman D, et al. (2022). Safety profile of bremelanotide across the clinical development program. Journal of Women's Health. Find on PubMed
Community reports
Anecdotal — not scientific evidence
Lived experience is valuable context and often surfaces problems before the literature does. It is also uncontrolled, unverified and subject to bias, so it never overrides published findings here.
Editorial evidence status
MixedCommunity discussion of this compound is widespread, but no independently verified reports were available for this analysis. Anecdotes have not been invented or treated as clinical evidence.
Buying Bremelanotide / PT-141 in Australia: what to check first
APEDRA does not sell Bremelanotide / PT-141 or any other product, and takes no commission from suppliers. If you are researching where to buy it, the biggest practical risk is not the compound itself but what is actually in the bottle: under-dosing, substitution with a different compound, and contamination are all documented in independent testing of online research chemicals.
- Ask for a batch-specific third-party lab report (HPLC/mass spectrometry), not a generic certificate.
- Check independent review platforms, not only reviews hosted on the seller's own site.
- Read the shipping, returns and refund policies before ordering.
- Be wary of prices far below the market or exaggerated results claims.
Compare Australian vendors independently · how we assess suppliers
Terms used here are defined in our glossary, and the evidence-grading scale explains what this analysis's grade means. If you believe something here is wrong, tell us.
This analysis is educational. It is not medical advice, a dosing recommendation, or an endorsement of use. Speak with a qualified medical practitioner about your circumstances.